Osteoporosis: Discontinuing denosumab discouraged
- PMID: 28835672
- DOI: 10.1038/nrrheum.2017.144
Osteoporosis: Discontinuing denosumab discouraged
Comment on
-
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.Bone. 2017 Dec;105:11-17. doi: 10.1016/j.bone.2017.08.003. Epub 2017 Aug 5. Bone. 2017. PMID: 28789921
References
-
- Bone. 2017 Aug 5;105:11-17 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical